Welcome to our dedicated page for Imac Hldgs news (Ticker: BACK), a resource for investors and traders seeking the latest updates and insights on Imac Hldgs stock.
IMAC Holdings reports company developments centered on Ignite Proteomics, its subsidiary focused on functional proteomics for precision oncology. News has covered Ignite’s Reverse Phase Protein Array technology, its CLIA-certified, CAP-accredited laboratory, and clinical RPPA assays that measure phospho- and total-protein biomarkers from small biopsy samples.
Recurring updates include research collaborations with health systems and academic medical centers, biomarker studies in breast and gastrointestinal cancers, publications on protein activation analysis, and the completed transfer of Proprietary Laboratory Analyses code 0249U for a proteomic breast cancer assay. Corporate news has also included public-company reporting and listing-compliance matters.
IMAC Holdings announced a registered direct offering to institutional investors for 5,164,474 shares at $0.76 per share, expected to close by August 16, 2022. This offering, along with a concurrent private placement, is projected to generate approximately $3.9 million before expenses. The firm will use these proceeds for working capital and strategic activities. Additionally, the investors will receive Series 1 and Series 2 warrants to purchase the same number of shares at an exercise price of $0.95, exercisable six months post-issuance.
IMAC Holdings, Inc. (BACK) has announced a price increase for its chiropractic and Performance Zone memberships at The BackSpace, effective August 2022. The monthly membership fee for chiropractic care has risen by $7 to $72, while individual chiropractic adjustments remain at $25. The newly introduced Performance Zone offers stretching services, aimed at enhancing musculoskeletal health through various techniques. Individual stretching sessions are priced at $35, with the initiative expected to expand the customer base without incurring significant additional costs.